Insights

Acquisition Legacy Following the 2017 merger that formed Alfasigma from Sigma-tau and related entities, there is an implied integration of strengths, suggesting potential cross-sell opportunities with Alfasigma’s broader portfolio and distributor channels.

Mid-size Footprint Sigma-tau operates with an employee base of 201-500 and annual revenue in the 25 to 50 million USD range, indicating a mid-size company profile that may be open to partnerships, contract manufacturing, or co-development deals to scale capabilities.

Funding Signals Revenue band positioning hints at growth potential and readiness for collaboration on phase-appropriate programs, including niche generics, specialty therapeutics, or late-stage development partnerships.

Tech Stack Readiness Adoption of common web and software technologies suggests modern digital capabilities; leverage this to propose digital health, data analytics, or process optimization collaborations that align with current IT footprints.

Competitive Positioning As part of a larger post-merger entity in the pharmaceutical space, there may be appetite for strategic alliances that complement rival portfolios (e.g., joint ventures, licensing, or contract manufacturing) to broaden market reach and accelerate time-to-market.

Similar companies to Sigma-tau

Sigma-tau Tech Stack

Sigma-tau uses 8 technology products and services including Google Hosted Libraries, Open Graph, Cloudflare, and more. Explore Sigma-tau's tech stack below.

Google Hosted Libraries
Content Delivery Network
Open Graph
Content Management System
Cloudflare
Content Management System
Cloudflare DNS
Domain Name Services
Google Fonts API
Font Scripts
jQuery
Javascript Libraries
Microsoft ASP.NET
Web Frameworks
Microsoft IIS
Web Servers

Sigma-tau's Email Address Formats

Sigma-tau uses at least 1 format(s):

Sigma-tau Email Formats	Example	Percentage
First.Last@sigma-tau.it	John.Doe@sigma-tau.it	88%
Last.First@sigma-tau.it	Doe.John@sigma-tau.it	7%
First.MiddleLast@sigma-tau.it	John.MichaelDoe@sigma-tau.it	4%
FirstMiddle.Last@sigma-tau.it	JohnMichael.Doe@sigma-tau.it	1%

Frequently Asked Questions

What is Sigma-tau's official website and social media links?

Sigma-tau's official website is sigma-tau.it and has social profiles on LinkedIn.

How much revenue does Sigma-tau generate?

As of July 2026, Sigma-tau's annual revenue is estimated to be $25M - $50M.

What is Sigma-tau's NAICS code?

Sigma-tau's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sigma-tau have currently?

As of July 2026, Sigma-tau has approximately 423 employees across 5 continents, including EuropeAsiaNorth America. Key team members include Head Of Molecular Oncology Laboratory: F. M. M.Resp. Ufficio Organo Di Vigilanza Gruppo Sigma-Tau: D. D.Laboratory Head; Biothechnology Department: O. M.. Explore Sigma-tau's employee directory with LeadIQ.

What industry does Sigma-tau belong to?

Sigma-tau operates in the Pharmaceutical Manufacturing industry.

What technology does Sigma-tau use?

Sigma-tau's tech stack includes Google Hosted LibrariesOpen GraphCloudflareCloudflare DNSGoogle Fonts APIjQueryMicrosoft ASP.NETMicrosoft IIS.

What is Sigma-tau's email format?

Sigma-tau's email format typically follows the pattern of First.Last@sigma-tau.it. Find more Sigma-tau email formats with LeadIQ.

When was Sigma-tau founded?

Sigma-tau was founded in 1957.

Sigma-tau

Q: What is Sigma-tau's official website and social media links?

Sigma-tau's official website is sigma-tau.it. Sigma-tau has social profiles on LinkedIn.

Q: How many employees does Sigma-tau have currently?

Sigma-tau has approximately 423 employees.

Q: What technology does Sigma-tau use?

Sigma-tau's tech stack includes MySQL, WordPress, Azure Front Door, Microsoft HTTPAPI, Cloudflare DNS.

Q: What is Sigma-tau's NAICS code?

Sigma-tau's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical Manufacturing201-500 Employees

Sigma-tau operated in pharmaceutical manufacturing and had a workforce in the hundreds. On August 1, 2017, it became part of a merger by incorporation with Alfa Wassermann S.p.A., Sigma-Tau Industrie Farmaceutiche Riunite S.p.A, and Biofutura Pharma S.p.A., forming Alfasigma S.p.A. The transaction created a new entity within the pharmaceutical sector.

The announcement notes that Sigma-tau's page would be inactive, directing followers to Alfasigma's LinkedIn presence. This reflects a transition of Sigma-tau into the larger Alfasigma structure; no further product or customer details are provided.